Murdock Hunter's most recent trade in Axsome Therapeutics Inc was a trade of 7,500 Common Stock done at an average price of $102.5 . Disclosure was reported to the exchange on June 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Axsome Therapeutics Inc | Hunter Murdock | General Counsel | Sale of securities on an exchange or to another person at price $ 102.47 per share. | 20 Jun 2025 | 7,500 | 0 (0%) | 0% | 102.5 | 768,525 | Common Stock |
| Axsome Therapeutics Inc | Hunter Murdock | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.91 per share. | 20 Jun 2025 | 7,500 | 7,500 (0%) | 0% | 29.9 | 224,325 | Common Stock |
| Axsome Therapeutics Inc | Hunter Murdock | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2025 | 7,500 | 22,383 | - | - | Stock Option (Right to Buy) | |
| Axsome Therapeutics Inc | Hunter Murdock | General Counsel | Sale of securities on an exchange or to another person at price $ 100.12 per share. | 20 Jun 2025 | 6,014 | 0 (0%) | 0% | 100.1 | 602,122 | Common Stock |
| Axsome Therapeutics Inc | Hunter Murdock | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.91 per share. | 20 Jun 2025 | 6,014 | 6,014 (0%) | 0% | 29.9 | 179,879 | Common Stock |
| Axsome Therapeutics Inc | Hunter Murdock | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2025 | 6,014 | 16,369 | - | - | Stock Option (Right to Buy) | |
| Axsome Therapeutics Inc | Hunter Murdock | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.91 per share. | 16 Jun 2025 | 7,500 | 7,500 (0%) | 0% | 29.9 | 224,325 | Common Stock |
| Axsome Therapeutics Inc | Hunter Murdock | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2025 | 7,500 | 29,883 | - | - | Stock Option (Right to Buy) | |
| Axsome Therapeutics Inc | Hunter Murdock | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2025 | 7,500 | 37,383 | - | - | Stock Option (Right to Buy) | |
| Axsome Therapeutics Inc | Hunter Murdock | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2025 | 7,500 | 44,883 | - | - | Stock Option (Right to Buy) | |
| Axsome Therapeutics Inc | Hunter Murdock | General Counsel | Sale of securities on an exchange or to another person at price $ 100.90 per share. | 16 Jun 2025 | 7,500 | 0 (0%) | 0% | 100.9 | 756,750 | Common Stock |
| Axsome Therapeutics Inc | Hunter Murdock | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.91 per share. | 16 Jun 2025 | 7,500 | 7,500 (0%) | 0% | 29.9 | 224,325 | Common Stock |
| Axsome Therapeutics Inc | Hunter Murdock | General Counsel | Sale of securities on an exchange or to another person at price $ 100.26 per share. | 16 Jun 2025 | 7,500 | 0 (0%) | 0% | 100.3 | 751,950 | Common Stock |
| Axsome Therapeutics Inc | Hunter Murdock | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.91 per share. | 16 Jun 2025 | 7,500 | 7,500 (0%) | 0% | 29.9 | 224,325 | Common Stock |
| Axsome Therapeutics Inc | Hunter Murdock | General Counsel | Sale of securities on an exchange or to another person at price $ 102.42 per share. | 16 Jun 2025 | 7,500 | 0 (0%) | 0% | 102.4 | 768,150 | Common Stock |
| Axsome Therapeutics Inc | Hunter Murdock | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 7,816 | 7,816 | - | - | Employee Stock Option (Right to Buy) | |
| Axsome Therapeutics Inc | Hunter Murdock | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 7,740 | 7,740 | - | - | Performance Stock Units | |
| Axsome Therapeutics Inc | Hunter Murdock | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 7,740 | 7,740 | - | - | Restricted Stock Units | |
| Axsome Therapeutics Inc | Murdock Hunter | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 23,593 | 23,593 | - | - | Employee Stock Option (Right to Buy) | |
| Axsome Therapeutics Inc | Murdock Hunter | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 12,956 | 12,956 | - | - | Restricted Stock Units | |
| Axsome Therapeutics Inc | Hunter Murdock | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 29,773 | 29,773 | - | - | Employee Stock Option (Right to Buy) | |
| Axsome Therapeutics Inc | Hunter Murdock | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 16,883 | 16,883 | - | - | Restricted Stock Units |